Evaluation of the association of vitamin D deficiency with gonadotropins and sex hormone in obese and non-obese women with polycystic ovary syndrome;Procjena povezanosti nedostatka vitamina D s gonadotropnim i spolnim hormonima u pretilih i žena koje nisu pretile sa sindromom policističnih jajnika

Medicinski Glasnik

Volumn 11, Issue 1, 2014, Pages 170-176

  Velija Ašimi, Zelija ^a  

^a University Clinical Centre of Sarajevo   (Bosnia and Herzegovina)

Author keywords

BMI; Insulin resistance; SHBG; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ANDROSTENEDIONE; C REACTIVE PROTEIN; FOLLITROPIN; GLUCOSE; LIPID; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; GONADOTROPIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; RADIOIMMUNOASSAY; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE; BLOOD; COMPLICATION; YOUNG ADULT;

ADULT; FEMALE; GONADAL STEROID HORMONES; GONADOTROPINS; HUMANS; OBESITY; POLYCYSTIC OVARY SYNDROME; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84893243275     PISSN: 18400132     EISSN: 18402445     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Wamberg L, Christiansen T, Paulsen SK, Fisker S, Rask P, Rejnmark L, Richelsen B, Pedersen SB. Expression of vitamin D-metabolizing enzymes in human adipose tissue-the effect of obesity and diet-induced weight loss. Int J Obes (London) 2013; 37:651-7.
2. Kabadi SM, Lee BK, Liu L. Joint effects of obesity and vitamin D insufficiency on insulin resistance and type 2 diabetes: results from the NHANES 2001-2006. Diabetes Care 2012; 35:2048-54.
3. Diamanti-Kandarakis E. Phenotypes and environmental factors in PCOS. 13th European Congress of Endocrinology, Rotterdam, The Netherlands, 30 April 2011-04 May 2011. Endocrine Abstracts 26 S28.1., p 37. European Society of Endocrinology, Bristol, UK, 2011.
4. Krishnan AV, Swami S, Peng L, Wang J, Moreno J, Feldman D. Tissue-selective regulation of 798 aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology 2010; 151:32-42.
5. Kinuta K, Tanaka H, Moriwake T, Aya K, Kato S, Seino Y. Vitamin D is an important factor in 787 oestrogen biosynthesis of both female and male gonads. Endocrinology 2000; 141:1317-24.
6. Blomberg Jensen M. Vitamin D metabolism, sex hormones, and male reproductive function. Reproduction 2012; 144:135-52.
7. Oury F, Sumara G, Sumara O, Ferron M, Chang H, Smith CE, Hermo L, Suarez S, Roth BL, Ducy P, Karsenty G. Endocrine regulation of male fertility by the skeleton. Cell 2011; 144:796-809.
8. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19:41-7.
9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-9.
10. Lerchbaum E, Obermayer-Pietsch B. Vitamin D and fertility: a systematic review. Eur J Endocrinol 2012; 166:765-78.
11. Thomson RL, Spedding S, Buckley JD. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2012; 77:343-50.
12. Wehr E, Pilz S, Schweighofer N, Giuliani A, Kopera D, Pieber TR, Obermayer-Pietsch B. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol 2009; 161:575-82.
13. Muscogiuri G, Policola C, Prioletta A, Sorice G, Mezza T, Lassandro A, Della Casa S, Pontecorvi A, Giaccari A. Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS? Clin Nutr 2012; 31:476-80.
14. Patra SK, Nasrat H, Goswami B, Jain A. Vitamin D as a predictor of insulin resistance in Polycystic Ovarian Syndrome. Diabetes Metab Syndr 2012; 6:146-9.
15. Ardabili HR, Gargari BP, Farzadi L. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutr Res 2012; 32:195-201.
16. Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S, Kimmig R, Mann K, Janssen OE. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006; 114:577-83.
17. Wehr E, Pieber TR, Obermayer-Pietsch B. Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: a pilot study. J Endocrinol Invest 2011; 34:757-63.